leflunomide

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Brain and Central Nervous System Tumors

Drug Information

Target Indication

Brain and Central Nervous System Tumors

Clinical Trial

Last updated: 1/23/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

VTRS

MYLAN

Related Pipeline

Hemophilia B

Smoking Cessation

Pneumococcal Disease

Overactive Bladder

Advanced Breast Cancer Female